In prostate cancer-derived cells, PAR1 over-expression has also been documented and has been linked to PAR1-stimulated activation of NF-κB, with an increase in NF-κB-regulated inflammatory cytokines like IL-6 and IL-8 [21]. This evidence concerns the gene F2R and prostate cancer.